124 related articles for article (PubMed ID: 8096880)
1. [Effects of inhaled beta-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with pulmonary emphysema].
Igarashi T; Nishimura M; Akiyama Y; Yamamoto M; Kobayashi S; Miyamoto K; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):32-6. PubMed ID: 8096880
[TBL] [Abstract][Full Text] [Related]
2. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
[TBL] [Abstract][Full Text] [Related]
3. [Effects of oxitropium bromide on exercise and lung function in patients with pulmonary emphysema].
Nakanishi N; Ueda N; Kitade M; Moritaka T; Kamei T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):38-42. PubMed ID: 9071154
[TBL] [Abstract][Full Text] [Related]
4. [Effects of inhaled anticholinergic agents and beta 2-agonists on distilled water induced cough in patients with chronic cough].
Tanaka S
Arerugi; 1996 Jan; 45(1):17-27. PubMed ID: 8851312
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
Koyama H; Nishimura K; Ikeda A; Izumi T
Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
Andò F; Ruggeri P; Girbino G; Cazzola M
Respir Med; 2008 Jun; 102(6):815-8. PubMed ID: 18343646
[TBL] [Abstract][Full Text] [Related]
7. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
[TBL] [Abstract][Full Text] [Related]
10. Duration of protection by oxitropium bromide against cholinergic challenge.
Wilson NM; Green S; Coe C; Barnes PJ
Eur J Respir Dis; 1987 Nov; 71(5):455-8. PubMed ID: 3327703
[TBL] [Abstract][Full Text] [Related]
11. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD.
Saito S; Miyamoto K; Nishimura M; Aida A; Saito H; Tsujino I; Kawakami Y
Chest; 1999 Feb; 115(2):376-82. PubMed ID: 10027435
[TBL] [Abstract][Full Text] [Related]
13. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.
Minette A; Marcq M
Rev Inst Hyg Mines (Hasselt); 1979; 34(3):115-23. PubMed ID: 45210
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
Fujimura M; Kamio Y; Matsuda T; Hashimoto T
Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
[TBL] [Abstract][Full Text] [Related]
16. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma.
Taube C; Kanniess F; Grönke L; Richter K; Mücke M; Paasch K; Eichler G; Jörres RA; Magnussen H
Respir Med; 2003 May; 97(5):568-77. PubMed ID: 12735677
[TBL] [Abstract][Full Text] [Related]
18. [The effect of bronchodilators in aerosol form on pulmonary function in patients with pulmonary emphysema].
Bosnjak-Petrović V; Radovanović S
Plucne Bolesti; 1989; 41(1-2):72-4. PubMed ID: 2798578
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
Frith PA; Jenner B; Atkinson J
Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116
[TBL] [Abstract][Full Text] [Related]
20. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night].
Kneubühler HR; Kyd K; Benoit RC; Scherrer M
Schweiz Med Wochenschr; 1980 May; 110(21):812-6. PubMed ID: 7394499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
